Prevention of Recurrent Nephrolithiasis

  • Charles Y. C. Pak
Part of the Topics in Renal Medicine book series (TIRM, volume 5)

Abstract

The management of nephrolithiasis encompasses two approaches, broadly categorized as surgical and medical. The objective of “surgical approach,” by classical open surgery or by recent techniques of endourology or extracorporeal shock wave lithotripsy, is the removal of existing stones which are causing pain, bleeding, or infection.

Keywords

Placebo Fatigue Crystallization Magnesium Diarrhea 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Blacklock, N.J. 1965. The pattern of urolithiasis in the Royal Navy Surgery Session. J.R. Navy Med. Serv. 51:99–111.Google Scholar
  2. 2.
    Williams, R. E. 1983. Long term survey of 538 patients with upper urinary stone. Br. J. Urol. 35:416–437.CrossRefGoogle Scholar
  3. 3.
    Coe, F.L., Keck, J. and Norton, E. R. 1977. The natural history of calcium urolithiasis. JAMA 238:1519–1523.PubMedCrossRefGoogle Scholar
  4. 4.
    Hosking, D.H., Erickson, S.B., Van Den Berg, C.J., Wilson, D.M. and Smith, L.H. 1983. The stone clinic effect in patients with idiopathic calcium urolithiasis. J. Urol. 130:1115–1118.PubMedGoogle Scholar
  5. 5.
    Pak, C.Y.C. 1982. Medical management of nephrolithiasis. J. Urol. 128:1157–1164.PubMedGoogle Scholar
  6. 6.
    Pak, C.Y.C, Peters, P., Hurt, G., Kadesky, M., Fine, M., Reisman, D., Splann, F., Caramela, C, Freeman, A., Britton, F., Sakhaee, K. and Breslau, N. A. 1981. Is selective therapy of recurrent nephrolithiasis possible? Am. J. Med. 71:615–622.PubMedCrossRefGoogle Scholar
  7. 7.
    Segura, J.W., Patterson, D.E., LeRoy, A.J., May, G. R. and Smith, L.H. 1983. Percutaneous lithotripsy. J. Urol. 130:1051–1054.PubMedGoogle Scholar
  8. 8.
    Chaussy, C, Brendel, W. and Schmiedt, E. 1980. Extracorporeally induced destruction of kidney stones by shock waves. Lancet 2:1265–1267.PubMedCrossRefGoogle Scholar
  9. 9.
    Pak, C.Y.C, Fuller, C, Sakhaee, K., Preminger, G. and Britton, F. 1985. Long-term treatment of calcium nephrolithiasis with potassium citrate. J. Urol. 134:11–19.PubMedGoogle Scholar
  10. 10.
    Preminger, G.M., Peterson, R., Peters, P.C. and Pak, C.Y.C 1985. The current role of medical treatment of nephrolithiasis: the impact of improved techniques of stone removal. J. Urol. 134:6–10.PubMedGoogle Scholar
  11. 11.
    Lawoyin, S., Sismilich, S., Browne, R. and Pak, C.Y.C. 1979. Bone mineral content in patients with primary hyperparathyroidism, osteoporosis, and calcium urolithiasis. Metabolism 28:1250–1254.PubMedCrossRefGoogle Scholar
  12. 12.
    Pak, C.Y.C, Nicar, M.J. and Northcutt, C. 1982. The definition of the mechanism of hypercalciuria is necessary for the treatment of recurrent stone formers. In Contributions to Nephrology G.M. Berlyne, S. Giovannetti and S. Thomas (ed.). Basel: S Karger, pp. 136–151.Google Scholar
  13. 13.
    Preminger, G.M., Sakhaee, K. and Pak, C.Y.C. 1987. Altered intestinal calcium absorption occurring independently of vitamin D in distal renal tubular acidosis. Metabolism 36:176–179.PubMedCrossRefGoogle Scholar
  14. 14.
    Pak, C Y. C, Sakhaee, K. and Fuller, C 1986. Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int. 30:422–428.PubMedCrossRefGoogle Scholar
  15. 15.
    Pak, C.Y. C. 1982. Should patients with single renal stone occurrence undergo diagnostic evaluation? J. Urol. 127:855–858.PubMedGoogle Scholar
  16. 16.
    Preminger, G. M., Harvey, J.A., Pak, C.Y.C. 1985. Comparative efficacy of “specific” potassium citrate therapy vs. conservative management in nephrolithiasis of mild-moderate severity. J. Urol. 134:658–661.PubMedGoogle Scholar
  17. 17.
    Pak, C. Y. C, Sakhaee, K., Crowther, C. and Brinkley, L. 1981. Evidence justifying a high fluid intake in treatment of nephrolithiasis. Ann. Intern. Med. 93:36–39.Google Scholar
  18. 18.
    Zarembski, P.M. and Hodgkinson, A. 1969. Some factors influencing the urinary excretion of oxalic acid in man. Clin. Chim. Acta 25:1–10.PubMedCrossRefGoogle Scholar
  19. 19.
    Pak, C.Y. C. 1981. A cautious use of sodium cellulose phosphate in the management of calcium nephrolithiasis. Invest. Urol. 19:187–190.PubMedGoogle Scholar
  20. 20.
    Brinkley, L., McGuire, J., Gregory, J. and Pak, C.Y.C. 1981. Bioavailability of oxalate in foods. Urology 17:534–538.PubMedCrossRefGoogle Scholar
  21. 21.
    Brickman, A.S., Massry, S.G., Coburn, J.W. 1972. Changes in serum and urinary calcium during treatment with hydrochlorothiazide studies on mechanisms. J. Clin. Invest. 51:945–954.PubMedCrossRefGoogle Scholar
  22. 22.
    Nicar, M.J., Peterson, R. and Pak, C.Y. C. 1984. Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis. J. Urol. 131:430–433.PubMedGoogle Scholar
  23. 23.
    Coe, F.L., 1978. Hyperuricosuric calcium oxalate nephrolithiasis. Kidney. Int. 13:418–426.PubMedCrossRefGoogle Scholar
  24. 24.
    Shorr, E. and Carter, A.C., 1950. Aluminum gels in the management of renal phosphatic calculi. J.A.M.A. 144:1549.Google Scholar
  25. 25.
    Lotz, M., Zisman, E. and Bartter, F. C. 1968. Evidence for phosphorus-depletion syndrome in man. N. Engl. J. Med. 278:409–415.PubMedCrossRefGoogle Scholar
  26. 26.
    Pak, C.Y.C., Delea, C. S. and Bartter, F.C. 1974. Successful treatment of recurrent nephrolithiasis (calcium stones) with cellulose phosphate. N. Engl. J. Med. 290:175–180.PubMedCrossRefGoogle Scholar
  27. 27.
    Pak, C.Y.C., Britton, F., Peterson, R., Ward, D., Northcutt, C, Breslau, N.A., McGuire, J., Sakhaee, K., Bush, S., Nicar, M., Norman D. and Peters, P. 1980. Ambulatory evaluation of nephrolithiasis: classification, clinical presentation and diagnostic criteria. Am. J. Med. 69: 19–30.PubMedCrossRefGoogle Scholar
  28. 28.
    Preminger, G. M. and Pak, C.Y. C. 1987. Eventual attenuation of hypocalciuric réponse to hydrochlorothiazide in absorptive hypcrcalciuria. J. Urol 137:1104–1108.PubMedGoogle Scholar
  29. 29.
    Pak, C.Y. C. and Galosy, R. A. 1980. Propensity for spontaneous nucleation and calcium oxalate. Quantitative assessment of urinary FPR-APR discriminant score. Am. J. Med. 69: 681–689.PubMedCrossRefGoogle Scholar
  30. 30.
    Pak, C.Y.C., Peterson, R., Sakhaee, K., Fuller, C, Preminger, G. and Reisch, J. 1985. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis. Am. J. Med. 79:284–288.PubMedCrossRefGoogle Scholar
  31. 31.
    Ettinger, B., Oldroyd, N.O. and Sorgel, F. 1980. Triamterene nephrolithiasis. JAMA 244:2443–2445.PubMedCrossRefGoogle Scholar
  32. 32.
    Leppla, D., Browne, R., Hill, K. and Pak, C. Y. C. 1983. Effect of amiloride with or without hydrochlorothiazide on urinary calcium and saturation of calcium salts. J. Clin. Endocrinol. Metab. 57:920–924.PubMedCrossRefGoogle Scholar
  33. 33.
    Broadus, A.E., Magee, J.S., Mallette, L.E., Horst, R.L., Lang, R., Jensen, P.S., Gertner, J. M. and Baron, R. 1983. A detailed evaluation of oral phosphate therapy in selected patients with primary hyperparathyroidism. J. Clin. Endocrinol Metab. 56:953–961.PubMedCrossRefGoogle Scholar
  34. 34.
    Gallagher, J.C. and Nordin, B.E.C. 1972. Treatment with oestrogens of primary hyperparathyroidism in post-menopausal women. Lancet i:503–507.CrossRefGoogle Scholar
  35. 35.
    Kaplan, R. A., Synder, W.H., Stewart, A. and Pak, C. Y.C. 1976 Metabolic effect of parathyroidectomy on asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 42:415–426.PubMedCrossRefGoogle Scholar
  36. 36.
    Pak, C.Y. C. 1979. Effect of parathyroidectomy on crystallization of calcium salts in urine of patients with primary hyperparathyroidism. Invest. Urol. 17:146–148.PubMedGoogle Scholar
  37. 37.
    Barilla, D.E., Zerwekh, J.E. and Pak, C.Y. C. 1979. A critical evaluation of the role of phosphate in the pathogenesis of absorptive hypercalciuria. Min. Elect Metab. 2:302–309.Google Scholar
  38. 38.
    Dudley, F.J. and Blackburn, C.R.B. 1970. Extraskeletal calcification complicating oral neutral-phosphate therapy. Lancet 2:628–630.PubMedCrossRefGoogle Scholar
  39. 39.
    Zerwekh, J.E., Pak, C.Y.C., Kaplan, R.A., McGuire, J. L., Upchurch, K., Breslau, N. and Johnson, R. 1980. Pathogenetic role of 1α, 25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy. J. Clin. Endocrinol. Metab. 51:381–386.PubMedCrossRefGoogle Scholar
  40. 40.
    Zerwekh, J.E., Harvey, J.A. and Pak, C.Y. C. Administration of pharmacologic amounts of 25(s), 26-dihydroxyvitamin D3 reduces serum 1,25-dihydroxyvitamin D3 levels in rats. Endocrinology, submitted for publication.Google Scholar
  41. 41.
    Pak, C. Y.C., Barilla, D.E., Holt, K., Brinkley, L., Tolentino, R. and Zerwekh, J.E. 1978. Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis. Am. J. Med. 65:593–599.PubMedCrossRefGoogle Scholar
  42. 42.
    Pak, C.Y.C., Holt, K. and Zerwekh, J.E. 1979. Attenuation by monosodium urate of the inhibitory effect of glycosaminoglycans on calcium oxalate nucleation. Invest. Urol. 17:138–140.PubMedGoogle Scholar
  43. 43.
    Pak, C. Y. C. and Peterson, R. 1986. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate. Arch Intern. Med. 146:863–868.PubMedCrossRefGoogle Scholar
  44. 44.
    Barilla, D.E., Notz, C, Kennedy, D. and Pak, C.Y.C. 1978. Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hyper-calciurias: effect of calcium and magnesium. Am. J. Med. 64:576–585.CrossRefGoogle Scholar
  45. 45.
    Harvey, J. A., Zobitz, M. M. and Pak, C. Y. C. 1985. Calcium citrate: reduced propensity for the crystallization of calcium oxalate in urine resulting from induced hypercalciuria of calcium supplementation. J. Clin. Endocrinol. Metab. 61:1223–1225.PubMedCrossRefGoogle Scholar
  46. 46.
    Preminger, G. M., Sakhace, K., Skurla, C. and Pak, C.Y.C. 1985. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J. Urol. 134:20–23.PubMedGoogle Scholar
  47. 47.
    Kassirer, J.P., Berkman, P.M., Lawrenz, D. R. and Schwartz, W. B. 1965. The critical role of chloride in the correction of hypokalemic alkalosis in man. Am. J. Med. 38:172–189.PubMedCrossRefGoogle Scholar
  48. 48.
    Pak, C.Y.C. and Fuller, C. 1986. Idiopathic hypocitraturic calcium oxalate nephrolithiasis successfully treated with potassium citrate. Ann. Intern. Med. 104:33–37.PubMedGoogle Scholar
  49. 49.
    Pak, C.Y.C. 1986. The problem of idiopathic stone formers presenting with no metabolic disorder: Pathogenesis and management. In Contributions to Nephrology. Third international Symposium on Recent Advances in Pathogenesis and Treatment of Nephrolithiasis. Basel: S Karger, in press.Google Scholar
  50. 50.
    Halperin, E.C., Thier, S.O. and Rosenberg, L. E. 1981. The use of d-pencillamine in cystinuria: Efficacy and untoward reactions. Yale J. Bio. Med. 54:439–446.Google Scholar
  51. 51.
    Crawhill, J. C, Scowen, E. F. and Watts, R. W. E. 1963. Effect of penicillamine on cystinuria. Br. Med. J. 1:585.CrossRefGoogle Scholar
  52. 52.
    Linari, F., Maragella, M., Fruttero, B. and Bruns, M. 1981. The natural history of cystinuria: a 15 year follow-up in 106 patients. In Urolithiasis, L. H. Smith, W. G. Robertson and B. Finlayson (eds.). New York: Plenum Press, p. 145.Google Scholar
  53. 53.
    Hautmann, R., Terhorst, B., Stuhisatz, H.W. and Lutzeyer, W. 1977. Mercaptopropionyl-glycine: a progress in cystine stone therapy. J. Urol. 117:628–630.PubMedGoogle Scholar
  54. 54.
    Pak, C.Y.C, Fuller, C, Sakhaee, K., Zerwekh, J.E. and Adams, B. V. 1986. Management of cystine nephrolithiasis with Alpha-mercaptopropionylglycine (Thiola). J. Urol. 136: 1003–1008.PubMedGoogle Scholar
  55. 55.
    Griffith, D.P. 1978. Struvite stones. Kidney Int. 13:372–382.PubMedCrossRefGoogle Scholar
  56. 56.
    Williams, J.J., Rodman, J. S. and Peterson, C. M. 1984. A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N. Engl. J. Med. 311:760–764.PubMedCrossRefGoogle Scholar
  57. 57.
    Pak, C.Y.C. 1987. Citrate and renal calculi. Min. Elect. Metab. In press.Google Scholar
  58. 58.
    Pak, C.Y.C, Sakhaee, K. and Fuller, C.J. 1983. Physiological and physicochemical prevention of calcium-stone formation by potassium citrate therapy. Trans. Assoc. Am. Physicians. 96:294–305.PubMedGoogle Scholar
  59. 59.
    Pak, C.Y.C. 1979. Physiological basis for absorptive and renal hypercalciurias. Am. J. Physiol. 237:F415–F423.PubMedGoogle Scholar
  60. 60.
    Pak, C Y. C 1983. Formation of renal stones may be prevented by restoring normal urinary composition. In Proceedings of the European Dialysis and Transplant Association, A. M. Davison (ed.). London: Pitman, pp. 371–385.Google Scholar
  61. 61.
    Backman, U., Danielson, B. G., Johansson, G., Ljunghall, S. and Wikstrom B. 1979. Treatment of recurrent calcium stone formation with cellulose phosphate. J. Urol. 123:9–13.Google Scholar
  62. 62.
    Pak, C.Y.C, Tolentino, R., Stewart, A. and Galosy, R.A. 1978. Enhancement of renal excretion of uric acid during long-term thiazide therapy. Invest. Unrol. 3:191–193.Google Scholar
  63. 63.
    Sakhaee, K., Nicar, M., Hill, K. and Pak, C.Y.C. 1983. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries an crystallization of stone-forming salts. Kidney Int. 24:348–352.PubMedCrossRefGoogle Scholar
  64. 64.
    Bordier, P., Ryckewart, A., Gueris, J. and Rasmussen, H. 1977. On the pathogenesis of so-called idiopathic hypercalciuria. Am. J. Med. 63:398–409.PubMedCrossRefGoogle Scholar
  65. 65.
    Hollified, J.W. 1986. Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy. Am. J. Med. 80(4A):8–12.CrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1987

Authors and Affiliations

  • Charles Y. C. Pak

There are no affiliations available

Personalised recommendations